Abstract
During the last years, solving the X-ray crystallographic structure of both the unliganded acetylcholinesterase (AChE) and AChE complexes with various inhibitors has provided valuable knowledge of the interactions that mediate inhibitor binding. This structural information allows us to rationalize differences in binding affinities for related analogues, and more importantly opens new strategies to design compounds with improved pharmacological properties. This is illustrated in the case of the recently reported huprines, which are a new class of very potent and selective acetylcholinesterase inhibitors.
Keywords: Acetylcholinesterase Inhibitors, Alzheimers Disease, Acetylcholinesterase Enzyme, Torpedo californica, AChE Inhibitors, Decamethonium, Edrophonium, (-)-Huperzina A, Donepezil
Mini-Reviews in Medicinal Chemistry
Title: Towards Improved Acetylcholinesterase Inhibitors: A Structural and Computational Approach
Volume: 1 Issue: 3
Author(s): X. Barril, M. Orozco and F. J. Luque
Affiliation:
Keywords: Acetylcholinesterase Inhibitors, Alzheimers Disease, Acetylcholinesterase Enzyme, Torpedo californica, AChE Inhibitors, Decamethonium, Edrophonium, (-)-Huperzina A, Donepezil
Abstract: During the last years, solving the X-ray crystallographic structure of both the unliganded acetylcholinesterase (AChE) and AChE complexes with various inhibitors has provided valuable knowledge of the interactions that mediate inhibitor binding. This structural information allows us to rationalize differences in binding affinities for related analogues, and more importantly opens new strategies to design compounds with improved pharmacological properties. This is illustrated in the case of the recently reported huprines, which are a new class of very potent and selective acetylcholinesterase inhibitors.
Export Options
About this article
Cite this article as:
Barril X., Orozco M. and Luque J. F., Towards Improved Acetylcholinesterase Inhibitors: A Structural and Computational Approach, Mini-Reviews in Medicinal Chemistry 2001; 1 (3) . https://dx.doi.org/10.2174/1389557013406828
DOI https://dx.doi.org/10.2174/1389557013406828 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of Obesity on Vascular Potassium Channels
Current Vascular Pharmacology The Pentacyclic Triterpenoids in Herbal Medicines and Their Pharmacological Activities in Diabetes and Diabetic Complications
Current Medicinal Chemistry Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology Histone Post-translational Modifications in Huntington’s and Parkinson’s Diseases
Current Pharmaceutical Design From Nature to Market: Examples of Natural Products that Became Drugs
Recent Patents on Biotechnology Genomic and Molecular Characterization of Alzheimer Disease
Current Psychiatry Reviews Editorial [Hot topic: Parkinsons Disease (Guest Editor: Jurgen Dinges)]
Current Topics in Medicinal Chemistry Acetylcholinesterase Imaging: Its Use in Therapy Evaluation and Drug Design
Current Pharmaceutical Design Neurobiology of Sleep Fragmentation: Cortical and Autonomic Markers of Sleep Disorders
Current Pharmaceutical Design Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation
Current Drug Targets An Overview on Potential Neuroprotective Compounds for Management of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Recent Progress in Drug Discovery for Parkinson's Disease)
Current Topics in Medicinal Chemistry Metabolic and Cardiovascular Ageing Indices in Relation to Glycated Haemoglobin in Healthy and Diabetic Subjects
Current Aging Science The Role of β-Amyloid Protein in Synaptic Function: Implications for Alzheimers Disease Therapy
Current Neuropharmacology Patent Selections
Recent Patents on Cardiovascular Drug Discovery Implication of Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegenerative Disorders – Contemporary Approaches
CNS & Neurological Disorders - Drug Targets Oxidative Stress: Apoptosis in Neuronal Injury
Current Alzheimer Research Tau Pathology and Future Therapeutics
Current Alzheimer Research Advanced Therapies For End-Stage Heart Failure
Current Cardiology Reviews An Effective Brain Imaging Biomarker for AD and aMCI: ALFF in Slow-5 Frequency Band
Current Alzheimer Research